---
category: news
title: "BioXcel Therapeutics Announces Expansion of Phase 2 Trial of BXCL701 in De Novo and Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer"
excerpt: "Initial findings from Phase 1b/2 trial of BXCL701 in combination with KEYTRUDA met efficacy threshold to support expansion of existing cohort of de novo and treatment-emergent Small-Cell Neuroendocrine Prostate Cancer (SCNC) High unmet medical need with no FDA approved therapies for patients presenting with SCNC Data from the trial,"
publishedDateTime: 2021-10-18T11:06:00Z
originalUrl: "https://www.tmcnet.com/usubmit/-bioxcel-therapeutics-announces-expansion-phase-2-trial-bxcl701-/2021/10/18/9471122.htm"
webUrl: "https://www.tmcnet.com/usubmit/-bioxcel-therapeutics-announces-expansion-phase-2-trial-bxcl701-/2021/10/18/9471122.htm"
type: article
quality: 0
heat: 0
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "Ka0RdCMQM6hc2dSGGkhBcUre8Qhgb4AJLG3aLDOei9nkrA9p5MVkrQ+8mEDTIjYDVbxbVAE4V4lXUQED195aRJ+T8MNZLuc74mDcW2sg9LkIsAsxZCTQzeepwoWRCIzAGVrQCyxkd2AlgYYkTitfhpmDxY72h49EMIcMy53m0oqotTnrAhG+0l1fCDhBdTRBuvGM2154bqr/k/Q+rjlp9o89RjbDCbQWH4Q8qmF6tk8RPr07bptI2TMGgo8A1qJ5FzIulb5DsKKy4jGi6r7B2F+0PKTWQQSpypEsc6RQrpeRkJTrrvydH5FwV6y2tM7nXxBKeii0UF5IRP/k1A/hc+RPwrYqLHj2TK5sIgS/s+s=;o5vFEMS3q48pH2vZ5vTJVw=="
---

